ランキング価格はじめての方へ
  1. 米国企業
  2. Travere Therapeutics, Inc.

Travere Therapeutics, Inc.TVTX

時価総額
$10.9億
PER
サマリーテーブルに戻る
損益計算書バランスシートキャッシュフロー
2012年
2月29日		2012年
12月31日		2013年
12月31日		2015年
12月31日		2016年
12月31日		2017年
12月31日		2018年
12月31日		2019年
12月31日		2020年
12月31日		2021年
12月31日		2022年
12月31日		2023年
12月31日
Product---------211201128
License---------171118
Total revenue---100134155164175198227212145
Product-----------8
License-----------3
Cost of goods sold------6567811
Research and development--------132210236245
Selling, general and administrative-1508093101104129136150220266
Change in fair value of contingent consideration-------1542215-
Restructuring-----4-0----11
Acquired IPR&D expense--------97---
Total operating expenses14,825------313374389479533
Total operating expenses14,825------313374389479533
Operating loss---23,972,073-51-58-54-80-137-176-162-267-388
Interest income-------1052622
Interest expense----8-1-1----20-11-11
Other income, net----0-01-0-01012
Loss on extinguishment of debt----4---17----8-
Total other income (expense), net---1561-5-22-9-13-18-1212
Interest income-------1052622
Interest expense----8-1-1----20-11-11
Other income, net----0-01-0-01012
Loss on extinguishment of debt----4---17----8-
Total other income (expense), net---1561-5-22-9-13-18-1212
Loss from continuing operations before income tax provision---33,747,734105-58-58-102-146-189-180-278-376
Income tax provision on continuing operations--75,775-12-1011-0-19000
Net loss-14,825-30,343,856-33,823,509117-48-60-103-146-169-180-278-111
Loss from continuing operations, net of tax-0.14-----------376
Earnings Per Share, Basic---3.49-1.29-1.54-2.54---3.01-4.37-1.5
Income from discontinued operations, net of tax-----------265
Earnings Per Share, Diluted---3.17-1.29-1.54-2.54---3.01-4.37-1.5
Net loss-14,825-30,343,856-33,823,509117-48-60-103-146-169-180-278-111
Income (Loss) from Continuing Operations, Per Basic Share------------5.07
Income (Loss) from Continuing Operations, Per Diluted Share------------5.07
Net income from discontinued operations, basic (in dollars per share)-----------3.57
Net income from discontinued operations, diluted (in dollars per share)-----------3.57
Net income (loss) per common share, basic (in dollars per share)---3.49-1.29-1.54-2.54---3.01-4.37-1.5
Net income (loss) per common share, diluted (in dollars per share)---3.17-1.29-1.54-2.54---3.01-4.37-1.5
Net loss-14,825-30,343,856-33,823,509117-48-60-103-146-169-180-278-111
Unrealized loss on defined benefit pension plan----------00
Foreign currency translation (loss) gain-------0-121-2
Unrealized gain (loss) on marketable debt securities---109,987-50-0-12-0-1-24
Comprehensive loss---33,933,496112-48-60-103-144-171-180-281-110
Net loss-14,825-30,343,856-33,823,509117-48-60-103-146-169-180-278-111
Unrealized loss on defined benefit pension plan----------00
Foreign currency translation (loss) gain-------0-121-2
Unrealized gain (loss) on marketable debt securities---109,987-50-0-12-0-1-24
Comprehensive loss---33,933,496112-48-60-103-144-171-180-281-110